抗体已经成为生物制药产业的重要支柱。针对肿瘤生物治疗抗体，介绍了基于抗体工程技术研究的最新进展：包括抗体人源化改造、人源抗体制备、抗体效应功能提高等技术研发情况。基于此，展望抗体研发的新方向。

The antibody has become an important pillar of the bio pharmaceutical industry. The development of the antibody used to cancer biological therapy was discussed on the basis of antibody engineering technology, including antibody humanization, human antibody preparation, effect function improvement, and so on. Furthermore, the novel direction of antibody research was forecasted.